CTOs on the Move

Sturdy Memorial Hospital

www.sturdymemorial.org

 
Sturdy Memorial Hospital Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Sturdy Memorial Hospital Inc. is based in Attleboro, MA. You can find more information on Sturdy Memorial Hospital Inc. at www.sturdymemorial.org
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mark Buttkus
Chief Technology Officer Profile

Similar Companies

Mason Wright Retirement Cmnty

Mason Wright Retirement Cmnty is a Springfield, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Central Georgia Health Network

CGHN has been a trusted partner for Central Georgia independent physicians for over 20 years, with proven success in favorable payouts, dividends and contracting. This commitment to physician independence is at the very heart of CGHN`s identity. CGHN`s ownership structure ensures independent physicians in Central Georgia maintain a strong, controlling governance voice. CGHN is a growing, clinically-integrated network representing nearly 1,000 independent physicians, healthcare professionals and hospital partners across Central Georgia. Our goal is to deliver the best patient care experiences, while enhancing care quality and lowering costs.

North River Village

North River Village is a Tuscaloosa, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PanOptica

At PanOptica, our aim is to develop new ocular therapies that help patients see their very best throughout their lives. Many patients with common eye diseases suffer debilitating vision loss, despite currently available treatments. At PanOptica, we understand the critical role vision plays in a patient`s quality of life. And we know the frustration eye care professionals face when they are unable to treat their patients successfully. Today, significant progress is being made in the field of ophthalmology, with small laboratories and large pharmaceutical companies alike exploring newer, more effective treatments for sight-threatening diseases. PanOptica seeks to license and develop these innovative therapeutics, which may include improvements to existing therapies or entirely new treatments for previously untreatable disorders. Our lead development compound, PAN-90806 , is a novel, small-molecule selective VEGF receptor antagonist that shows promise as a topical treatment for wet age-related macular degeneration and diabetic retinopathy.

Holston Medical Group

Established in 1977, HMG's multi-specialty physician practice includes more than 100 physicians and mid-level providers in its provision of 24-hour medical/surgical coverage.